BioDelivery Sciences International Investors
BioDelivery Sciences International is a private equity firm based in Raleigh, North Carolina, founded in 1997 The firm specializes in the development and commercialization of innovative therapeutics for patients with chronic pain and other debilitating conditions With a significant investment scale of approximately $10,500,000, BioDelivery Sciences focuses on advancing its proprietary drug delivery technologies The firm is committed to improving patient outcomes through its strategic partnerships and robust product pipeline BioDelivery Sciences International continues to play a vital role in the biopharmaceutical industry by addressing unmet medical needs
Estimated Revenue:
$50M to $100M
Funding Status:
IPO
Investor Type:
Private Equity Firms
Employee Number:
101-250
Industry:
FemTech
Headquarters:
USA
Founded Date:
1997
Technology:
Others